LuciPona 45 mg is a higher strength formulation of ponatinib used in the treatment of advanced or resistant leukemia. It is prescribed when lower doses or other treatments are not sufficient. This medicine is part of specialized oncology care in the United Kingdom, United States, Australia, Singapore and Philippines. LuciPona 45 mg helps slow disease progression and manage symptoms effectively when used under expert medical guidance.
Active Ingredient
Ponatinib is a potent tyrosine kinase inhibitor that targets multiple signaling pathways involved in cancer growth. It is especially effective against resistant mutations.
Uses of LuciPona 45 mg
• Treatment of advanced leukemia
• Management of resistant cancer cases
• Relief from disease symptoms
• Support for targeted therapy
How LuciPona 45 mg Works
Ponatinib blocks abnormal kinase activity in cancer cells preventing their growth and survival. This leads to reduced tumor burden and improved disease control.
How to Use LuciPona 45 mg
1. Take exactly as prescribed
2. Swallow whole with water
3. Do not change dose without advice
Possible Side Effects
• High blood pressure
• Fatigue
• Nausea
• Skin rash
Precautions
• Regular cardiovascular monitoring required
• Inform doctor about liver conditions
• Avoid use during pregnancy
Safety Information
Use only under specialist supervision. Close monitoring is essential due to potential serious side effects.
Storage
• Store in a cool dry place
• Protect from moisture
• Keep out of reach of children
